The Spring 2017 Research Roundtable Topic Meeting, "Innovative Trial Design for AD", will take place May 23-24th at the Park Hyatt Washington, D.C. 

The topic meeting will highlight the use of digital biomarkers, including wearable technology, and new recruitment technology. This meeting will provide a forum to discuss a broad range of technologies and how/what needs to be done to turn current and emerging digital technologies into tools to advance diagnosis and drug development. Experts in the field (academia, industry, federal agencies) will provide their perspectives and experiences, which may help establish a path forward for the development of new therapies in AD, using a broad range of digital technologies.